跳至主要内容
临床试验/NCT05904977
NCT05904977招募中不适用

Preliminary Study on the Metastatic Rate and Clinical Significance of the Anterior Leaf of Vesicouterine Ligament in Early Stage Cervical Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 个研究点 分布在 1 个国家目标入组 460 人开始时间: 2019年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
460
试验地点
1
主要终点
Metastatic rate of the anterior leaf of vesicouterine ligament

研究概览

简要总结

The purpose of this study is to preliminarily explore the metastatic rate and clinical significance of the anterior leaf of vesicouterine ligament resection for early stage cervical cancer, so as to further improve the postoperative quality of life of patients and reduce the incidence of postoperative urinary complications.

详细描述

The patients with cervical cancer who underwent abdominal radical hysterectomy(type C)plus pelvic lymph node dissection by the same surgical team at the Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, were included. According to the resection range of the anterior leaf of vesicouterine ligament (VUL), patients were divided into type C resection group (near the bladder wall) and B type resection group (above the ureter). The anterior leaf of the VUL in the type C resection group was sent to pathological biopsy separately, and the metastasis rate was further clarified by the pathological "ultrastaging" method. By comparing the clinicopathological characteristics of patients with metastasis and non-metastasis, the potential risk factors of VUL metastasis were analyzed. The oncological outcomes of patients with different resection range of the anterior VUL were compared. At the same time, the Functional Assessment of Cancer Therapy-Cervical(FACT-Cx)cervical cancer patient quality of life score table was used to evaluate cervical cancer patients after surgery. The relevant factors that may affect the quality of life score are included in the multiple linear regression analysis to obtain independent risk factors that affect the quality of life of the patient after surgery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Histological confirmation of squamous, adenocarcinoma, or adenosquamous cervical carcinoma (even neuroendocrine or clear cell carcinoma)
  • Radiographically confirmed tumor limited to the cervix or upper third vagina, but without evidence of lymph node metastasis
  • Stage IA2-IIA2 ( FIGO 2018)
  • Treated initially or just underwent cervical conization before
  • Underwent the abdominal type C (Q-M classification) radical hysterectomy with pelvic lymph node dissection by the same team
  • Underwent the bilateral type C AL-VUL resection during the surgery
  • The Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1

排除标准

  • Not stage IA2-IIA2 ( FIGO 2018)
  • History of abdominal or pelvic radiotherapy
  • Evidence of metastatic disease detected by PECT, MRI or CT
  • The surgeon evaluated the patient as unsuitable for abdominal radical hysterectomy or the patient as refusing abdominal surgery
  • Patients with other mailgnant tumors except cervical cancer
  • Incompetence of the clinical, surgical and pathological data

结局指标

主要结局

Metastatic rate of the anterior leaf of vesicouterine ligament

时间窗: 1 year (Postoperative pathological confirmation date)

The metastasis rate of anterior leaf of VUL (%) = (case number of positive metastatic lesion detected by H\&E staining + case number of positive metastatic lesion diagnosed by "ultrastaging") / Total number of the patients with cervical cancer who underwent abdominal radical hysterectomy(type C)plus pelvic lymph node dissection by the samesurgical team ×100%

次要结局

  • Incidence of postoperative adjuvant therapy in patients with metastasis in the anterior leaf of VUL(1 year after surgery)
  • Incidence of postoperative urinary dysfunction in two groups(1 year after surgery)
  • Postoperative quality of life scores in two groups(1,2,3 years after surgery)
  • DFS(3 years after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验